Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo efficacy
US9102635B2 · kind B2 · utility
0Cited by
23References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2014 |
| Grant date | Aug 11, 2015 |
| Priority date | — |
| Expiry date | Feb 12, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula I;or a pharmaceutically acceptable salt thereof, wherein X is defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.